A Study of LY4175408 in Participants With Advanced Cancer
Eli Lilly and Company
Eli Lilly and Company
Kivu Bioscience Inc.
Mersana Therapeutics
Bristol-Myers Squibb
Beijing Biotech
Exscientia AI Limited
Genmab
Epsilogen Ltd
IDEAYA Biosciences
Radiopharm Theranostics, Ltd
Eli Lilly and Company
University of Southern California
Eisai Inc.
PMV Pharmaceuticals, Inc
Mayo Clinic
NiKang Therapeutics, Inc.
Alterome Therapeutics, Inc.
BeOne Medicines
Accent Therapeutics
Seagen Inc.
Radiopharm Theranostics, Ltd
Tizona Therapeutics, Inc
A2 Biotherapeutics Inc.
Exscientia AI Limited
Normunity AccelCo, Inc.
NiKang Therapeutics, Inc.
Institute of Cancer Research, United Kingdom
Institut Curie
SystImmune Inc.
Eli Lilly and Company
Elephas
Apollo Therapeutics Ltd
Innate Pharma
Dren Bio
OncoNano Medicine, Inc.
Avenzo Therapeutics, Inc.
Volastra Therapeutics, Inc.
Maastricht University Medical Center
University of Kansas Medical Center
Hadassah Medical Organization
Nurix Therapeutics, Inc.
University of California, Irvine
Medicenna Therapeutics, Inc.
UNICANCER
Monopar Therapeutics
Monopar Therapeutics
Cofactor Genomics, Inc.
Light Chain Bioscience - Novimmune SA
Cancer Research UK
Innolake Biopharm